Acute weight gain after switch to emtricitabine/tenofovir alafenamide for human immunodeficiency virus pre-exposure prophylaxis

Shailendra V. Selvaraj, Sara H. Bares, Joshua P. Havens

Research output: Contribution to journalArticlepeer-review

Abstract

We report a case of acute weight gain after switching from emtricitabine/tenofovir disoproxil to emtricitabine/tenofovir alafenamide for human immunodeficiency virus pre-exposure prophylaxis.

Original languageEnglish (US)
JournalOpen Forum Infectious Diseases
Volume7
Issue number10
DOIs
StatePublished - Oct 1 2020

Keywords

  • Emtricitabine/tenofovir alafenamide
  • Preexposure prophylaxis
  • Weight gain

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Acute weight gain after switch to emtricitabine/tenofovir alafenamide for human immunodeficiency virus pre-exposure prophylaxis'. Together they form a unique fingerprint.

Cite this